A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer

about

A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer

Item

http://www.wikidata.org/entity/Q38723579

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A novel nonsense mutation in a ...... r treatment in prostate cancer

@en

type

Item

label

A novel nonsense mutation in a ...... r treatment in prostate cancer

@en

prefLabel

A novel nonsense mutation in a ...... r treatment in prostate cancer

@en

P1476

A novel nonsense mutation in a ...... r treatment in prostate cancer

@en

P2093

Dong Han

http://www.w3.org/2001/XMLSchema#string

Eric de Waal

http://www.w3.org/2001/XMLSchema#string

Jill A Macoska

http://www.w3.org/2001/XMLSchema#string

Jude Owiredu

http://www.w3.org/2001/XMLSchema#string

Kevin Valencia

http://www.w3.org/2001/XMLSchema#string

Shuai Gao

http://www.w3.org/2001/XMLSchema#string

Wanting Han

http://www.w3.org/2001/XMLSchema#string

P2860

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer

Integrative clinical genomics of advanced prostate cancer.

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth

Increased survival with enzalutamide in prostate cancer after chemotherapy

Abiraterone and increased survival in metastatic prostate cancer

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy.

Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor.

P304

6796-6808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.14296

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Changmeng Cai

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28036278

http://www.w3.org/2001/XMLSchema#string

P932

5351670

http://www.w3.org/2001/XMLSchema#string